Penumbral Rescue by Normobaric O=O Administration in Patients With Ischaemic Stroke and Target Mismatch ProFile: A Phase II Proof-of-Concept Trial

Informazioni relative al progetto

PROOF

ID dell’accordo di sovvenzione: 733379

DOI 10.3030/733379

Progetto chiuso

Data della firma CE 12 Dicembre 2016

Data di avvio 1 Gennaio 2017

Data di completamento 30 Giugno 2023

Finanziato da

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Costo totale € 5 247 102,54

Contributo UE € 5 246 831,94

Coordinato da

EBERHARD KARLS UNIVERSITAET TUEBINGEN
Germany

Risultati finali

Documents, reports (3)

PROOF exploitation strategy

This documents summarises the steps towards a PROOF exploitation strategy until M30 IMC set up M6 awarenessraising workshop on IP management M12 identification and information of relevant stakeholders M12 first IMC report including draft efficacy and safety case for the exploitation strategy M30

Final list of participating centres

Final list of participating centres.

PROOF communication and dissemination tools

This document summarises all communication and dissemination tools established during the first year: Press release at the time of the kick-off meeting (M1), graphic standards (M3), provisional public website goes live (M3), presentation leaflet and poster (M6), PROOF PowerPoint presentation (M6), PROOF website fully functional, including a secure intranet area (M6).

Other (1)

DSMB Formation

Data and Safety Monitoring Board Formation.

Pubblicazioni

Peer reviewed articles (1)

Normobaric hyperoxygenation: a potential neuroprotective therapy for acute ischemic stroke?

Autori: Sven Poli, Jean-Claude Baron, Aneesh B. Singhal, Florian Härtig
Pubblicato in: Expert Review of Neurotherapeutics, Numero 17/12, 2017, Pagina/e 1131-1134, ISSN 1473-7175
Editore: Future Drugs Ltd.
DOI: 10.1080/14737175.2017.1376657